imipenem, anhydrous has been researched along with Fournier Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cihan, A; Ferahköşe, Z; Karamercan, A; Menteş, BB; Naznedar, R; Sucak, G | 1 |
| Campo, C; Navarro, V; Salavert, M | 1 |
1 review(s) available for imipenem, anhydrous and Fournier Disease
| Article | Year |
|---|---|
[Fournier's gangrene. A study of 12 patients and a review].
Topics: Administration, Topical; Adult; Aged; Cefotaxime; Clindamycin; Combined Modality Therapy; Comorbidity; Diabetes Mellitus; Drug Therapy, Combination; Fournier Gangrene; Gentamicins; Humans; Imipenem; Length of Stay; Male; Middle Aged; Penicillins; Povidone-Iodine; Scrotum; Sucrose; Surgery, Plastic | 2000 |
1 other study(ies) available for imipenem, anhydrous and Fournier Disease
| Article | Year |
|---|---|
Fournier's gangrene after hemorrhoidectomy: association with drug-induced agranulocytosis. Report of a case.
Topics: Adult; Agranulocytosis; Anti-Inflammatory Agents, Non-Steroidal; Colon, Sigmoid; Colostomy; Dipyrone; Fluid Therapy; Fournier Gangrene; Granulocyte Colony-Stimulating Factor; Hemorrhoids; Humans; Imipenem; Laparoscopy; Male; Postoperative Complications; Recombinant Proteins; Risk Factors; Thienamycins; Treatment Outcome | 1999 |